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Abstract
Background: Cyclooxygenases (COXs) are the rate limiting enzymes in the process of prostaglandins (PGs)
synthesis, which are critical regulators of a number of reproductive processes, including ovulation, implantation,
decidualization and parturition. The aim of the present study was to investigate the expression and regulation of
COX-1 and COX-2 and levels of prostaglandins during rat pregnancy, in a model of pseudopregnancy and estrous
cycle.
Methods: Uteri were collected from the cyclic rats on each day of estrous cycle, after every two days for pregnant
(days 2 to 22) and pseudopregnant rats (days 1 to 9). In vitro primary endometrial stromal cells were cultured in
the presence of steroid hormones and their respective inhibitors for the possible modulation of COX-1 and COX-2.
Endometrial protein extracts were used for western blot analysis and tissue sections were prepared for protein
localization using immunofluorescence. Measurements of PGF2alpha and PGE2 metabolites in serum were
performed by enzyme immunoassay (EIA).
Results: COX-1 expression was found to be elevated during implantation and parturition, however, the levels of
COX-1 decreased during decidualization periods. COX-2 was detected during early pregnancy from day 2 to 5,
increased during decidual regression, and was also expressed at the time of parturition. COX-2 protein expression
was found to be increased at estrus phase in cyclic rats. Both enzymes were found to be modulated in the
endometrium of pseudopregnant rats, suggesting that they are regulated by 17beta-estradiol and progesterone. A
significant increase in PGE2 metabolite levels was observed on day 10, 12 and 14 of pregnancy. However, an
increase in PGF2alpha metabolite levels was observed only on day 14. The concentration of both these metabolites
changed during pseudopregnancy and maximum levels were observed at day 7. Significant increase in PGE2
metabolite was observed at proestrus phase, on the other hand, PGF2alpha metabolite was significantly increased
at proestrus and metestrus phase. COX-2 protein was regulated by 17beta-estradiol in cultured endometrial stromal
cells which was blocked in the presence of ICI-182,780.
Conclusions: Taken together, these results suggest that COX-1 and COX-2 could be differentially regulated by
steroid hormones and might be the key factors involved in embryo implantation, decidualization, decidua basalis
regression and parturition in rats.
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Cyclooxygenase (COX), the rate-limiting enzyme in
prostaglandin (PG) biosynthesis exists in two isoforms,
COX-1 and COX-2. These enzymes catalyze the conver-
sion of arachidonic acid into prostaglandin G2, which
are further peroxidised to prostaglandins PGH2 [1].
C O X - 1i sk n o w nt ob eac o n s t i t u t i v ee n z y m ee x p r e s s e d
in most tissues [2], whereas expression of COX-2 can be
induced by cytokines/growth factors or inflammatory
stimuli. Previous studies suggest that COX-1 plays a
crucial role during parturition [3], and COX-2 is impor-
tant during ovulation, fertilization, implantation and
decidualization [4]. Further, this fact is well supported
by gene knockout studies; COX-1-deficient female mice
are fertile with specific parturition defects, whereas
COX-2-deficient females are infertile with abnormalities
in ovulation, fertilization, implantation and decidualiza-
tion [4,5]. The processes of ovulation and implantation
are considered analogous to ‘proinflammatory’
responses; therefore, the involvement of PGs in these
processes has long been speculated.
Prostaglandins are lipid mediators that play an impor-
tant role in reproduction and maintainance of pregnancy
[6,7]. PGE synthase (PGES) is a terminal prostanoid
synthase and can enzymatically convert the cyclooxygen-
ase product PGH2 to PGE2 which can further bind to
and activate a set of functionally distinct cell surface
receptors - EP1, EP2, EP3 and EP4 [8]. PGE2 and PGI2
are suspected to be implicated in the increase of vascu-
lar permeability during implantation and are known to
be essential for decidualization [9]. Among various pros-
taglandins, PGF2a h a sa l s ob e e nc o n s i d e r e da st h ep r i -
mary candidate present during pregnancy, where PGF2a
plays a crucial role in myometrium during parturition
by increasing the oxytocin-induced contractions [10].
PGF2a is synthesized by PGF synthase and acts through
FP receptor.
To date, the regulation and role of each COX enzyme
and prostaglandin metabolite during pregnancy and
estrous cycle in rat uterus have not been fully under-
stood. Previously, we have shown that sex steroids regu-
late the expression of prostaglandin D synthase (PGDS)
and prostacyclin synthase (PGIS) during pregnancy [11].
Therefore, the rationale of the present study is that if
sex steroids could regulate the expression of PGDS and
PGIS during pregnancy. Hence these steroids might
play a pivotal role in the regulation of COX-1 and
COX-2 which are the first and rate limiting enzymes
for prostaglandin synthesis. In this study we investigated
the endometrial expression of COX-1 and COX-2 and
levels of prostaglandins metabolites during rat preg-
nancy, in a model of pseudopregnancy and during the
estrous cycle.
Methods
Reagents
COX-1 (murine) polyclonal antibody (Cat. No.160109),
and COX-2 (murine) affinity purified polyclonal anti-
body (Cat.No. 160126) were purchased from Cayman
Chemicals (Ann Arbor, MI). Prostaglandin F2 metabo-
lite 13,14-dihydro-15-keto PGF2a and prostaglandin E2
metabolite 11 beta-PGF2 were purchased from Cayman
Chemicals (Ann Arbor, MI). Vectastain ABC Kit for
rabbit IgG and Vector Nova Red were purchased from
Vector Laboratories Inc. (Burlingame, CA, USA). 17b-
estradiol (E2) and progesterone were purchased from
Laboratoire Mat (QC, Canada).
Animals
Sprague-Dawley female rats, 200-225 g, were obtained
from Charles River Laboratories Canada. Animals were
maintained on standard chow and water, which were
available ad libitum, in animal facilities illuminated
between 6:00 h and 20:00 h. All procedures were per-
formed in accordance with guidelines of the Canadian
Council on Animal Care for the handling and training
of laboratory animals and the Good Health and Animal
Care Committee of the Université du Québec à Trois-
Rivières. Stages of the estrous cycle were confirmed by
vaginal smears. Rats with three regular cycles of 4 days
were used in these experiments and killed at various
stages of the estrous cycle (diestrus, proestrus, estrus
and metestrus). Also, male and female mice were mated
overnight and pregnancy was confirmed by vaginal
smears and/or the presence of a vaginal plug (day 1).
Rats were killed on day 2, 4, 5, 6, 8, 10, 12, 14, 16, 18
and 20 of pregnancy at 10:00 h in the morning and at
18:00 h for days 5.5 and 6.5. Three to four different rats
were used for each time of pregnancy. Uteri were col-
lected and fixed for immunofluorescence staining (IF).
Endometrial protein extracts were collected for western
blot analysis.
Pseudopregnancy model
A total of 3 rats per day of pseudopregnancy were ovar-
iectomized and then allowed to recover from surgery for
a minimum of 10 days. They were pre-treated with phy-
siological doses of estradiol (1,3,5(10)-Estratriene-3,17b-
diol, Sigma-aldrich) and progesterone (Laboratoire Mat,
PQ) to induce decidualization as described previously
(19): 1) 0.2 ug estradiol injection per day for three days
(in the morning, day -2,-1 and 0); 2) On the third day
(day 0 of pseudopregnancy), another injection in the
afternoon of estradiol (0.2 μg) and progesterone (1 mg)
was performed; 3) No treatment for 2 days (day 1 and 2
of pseudopregnancy); 4) Injections of estradiol (0.1 μg)
and progesterone (4 mg) for three days (day 3, 4 and 5
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(0.1 μg) in the afternoon on day 7 (day 4 of pseudopreg-
nancy); 6) Rats were killed on day 1,3,5,7 and 9 of pseu-
dopregnancy. Uteri were collected and fixed for
immunofluorescence (IF) staining. Endometrial protein
extracts were collected for western blot analysis.
Endometrial stromal cell isolation, primary culture and
in vitro decidualization
Uteri were removed from the model of pseudopregnant
rats at day 5 using the same sex steroids treatment as
described above. Horns were taken and immersed in
HBSS solution containing HEPES (20 mM), penicillin
(100 units/ml), streptomycin (100 μg/ml) and fungizone
(1,25 μl/ml) (Invitrogen, ON, Canada). Further proces-
sing was performed in a sterile environment. The uter-
ine horns were transferred into a sterile petri plate
containing HBSS, slit longitudinally and immersed in
trypsin type I solution (0.3%) (Roche Diagnostics, QC,
Canada) in HBSS and agitated for 60 minutes at room
temperature. Uterine horns were then vortexed at maxi-
mum for 5 sec and supernatant containing epithelial
cells were discarded. Uterine horns were washed three
times with 2.5 ml of HBSS and immersed in a HBSS
solution containing trypsin type I (0.03%), DNAse I
(0.016%) and collagenase type II (0.064%) for 15 minutes
at 37°C in a water bath. Uterine horns were then vor-
texed again at maximum for 5 sec. The supernatant
containing stromal cells was transferred into a sterile
falcon tube containing 150 μl of FBS D.C. (Dextran-
Charcoal extracted). Uterine horns were washed twice
with 2.5 ml of HBSS and the supernatant was mixed
with stromal cells. Uterine horns were discarded and
stromal cells were centrifuged at 1000 g for 5 minutes.
Cells were washed twice with HBSS and centrifuged.
The supernatant was discarded and cells were diluted
with DMEM-F12 (pH 7.1) (Invitrogen, ON, Canada)
containing 2.438 g/L NaHCO3, 10% FBS D.C. and gen-
tamycine 50 μg/ml. Cells were incubated at 37°C in the
presence of 5% CO2. Cells were plated in 6-well plates
(Corning plates) at a density of 50% (4 × 10
5 cells per
well). The medium was changed two hours after the
first incubation in order to eliminate epithelial cell con-
tamination from stromal cell cultures. The purity of
stromal cells was more than 97%: cell culture contami-
nation with epithelial cells was evaluated by cellular
morphology and immunofluorescence using a Keratin 8/
18 antibody. Confluent cells (~90%) cells were then sti-
mulated with steroids (estradiol and progesterone) in
the presence and absence of respective blockers (ICI-
182,780 and RU-486). The cells were pre-treated with
ICI-182,780 and RU-486 at concentration of 1 μMf o r
1 hr, followed by the treatment of estradiol and proges-
terone at concentration of 100 nM for 48 h.
Immunofluorescence staining
The uterus was fixed in 4% paraformaldehyde solution
and embedded in paraffin. Tissue sections of 7 μm
thickness were mounted on polylysine-coated slides.
The slides were deparaffinized by heating at 60°C for
30 min followed by two washes in NeoClear solvent
(VWR Canlab, Mississauga, Canada) and progressively
hydrated with successive washes at room temperature in
100% ethanol, 95% ethanol in PBS, 70% ethanol in PBS,
and followed by PBS. After permeabilization for 6 min
in boiling citrate solution (0.1% sodium citrate, 0.1%Tri-
ton X-100 in water), the tissue slides were washed twice
with PBS at room temperature. Non-specific binding
sites were blocked by 1 h incubation with 2% bovine
serum at room temperature in a humidified chamber,
and the tissues were probed with rabbit anti-COX-1 or
COX-2 (murine) primary antibody diluted in blocking
s e r u m1 : 1 0 0o v e r n i g h ta t4 ° C .T h es l i d e sw e r ew a s h e d
twice with PBS, and the tissues were probed with Alexa
Fluor 488-conjugated anti-rabbit secondary antibody
diluted 1:200 (Cell Signaling Technology) for 1 h at
room temperature in a humidified chamber protected
from light. The slides were washed once with PBS and
counterstained with Hoechst nuclear dye followed by
two rinses with water. The tissues were covered with
0.1% para-phenylenediamine (PPDA) anti-fade reagent
and observed under a fluorescence microscope. Negative
controls were performed using the same protocol but
substituting the primary antibody with rabbit anti-GST
primary antibody (Cell Signaling Technology).
Protein extraction and western analysis
Protein homogenates from the pregnant rat endome-
trium were isolated as described previously [12]. Briefly,
uteri from day 2 to day 20 pregnant rats were rapidly
excised and placed in ice-cold saline until dissected.
Uteri were carefully laid on a glass plate and placed on
the stage of a dissecting microscope. In early pregnancy
(day 2 to 5.5), total endometrium was scraped using a
microscope glass and collected. Uteri from day 6 to 10
the placenta and decidua were at an early stage of differ-
entiation and could not be reliably separated. For this
reason, decidua basalis (DB) dissected from animals
between these days of pregnancy contains some chor-
ioallantoic cells, but antimesometrial decidua, choriovi-
telline tissues, fetus, and myometrium were removed.
Even though we carefully dissected DB from these tis-
sues, it is a possibility that a contamination with some
antimesometrial decidual cells that regress to form the
deciduas caspularis (DC) would occur. In uteri collected
from Day 12 to 20 pregnant rats, DB was isolated by
gently separating the placenta and myometrial regions
with 23-gauge needles. Additionally, the DB began to
regress on Day 14 and became too thin to reliably
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described previously by Ogle and George [13].
Endometrial cells from pregnant animals were homo-
genized using a pipette in RIPA lysis buffer (PBS 1× pH
7.4; 1% Nonidet P-40; 0.5% Sodium deoxycholate; 0.1%
SDS; Protease Inhibitor Cocktail Tablets (Roche Diag-
nostics Canada, PQ)). Homogenates were centrifuged
(12,000 × g for 20 min at 4°C) to remove insoluble
material. The supernatant was recovered and stored at
-20°C till further analysis. Protein content was deter-
mined with the Bio-Rad DC Protein Assay. Protein
extracts (50 μg) were heated at 94°C for 3 min, resolved
by 10% SDS-PAGE and electrotransferred to nitrocellu-
lose membranes using a semidry transfer apparatus
(Bio-Rad, Mississauga, ON). The membranes were then
blocked for 2 hrs at room temperature with PBS con-
taining 5% milk powder, then incubated with anti COX-
1 1:1000 and COX-2 1:2000 and subsequently with
horseradish peroxidase-conjugated anti-rabbit secondary
antibody (1:3000; room temperature for 45 min). All
membranes were stripped with Restore™ western blot
stripping buffer (Pierce, # 21059, lot # FH71541), and
reprobed with an antibody specific to b-actin which was
used as an internal standard. Peroxidase activity was
visualized with the Super signal® West Femto maximum
sensitivity substrate (Pierce, Arlington Heights, IL,
USA), according to the manufacturer’s instructions. Sig-
nal was visualized using the Biochemi Imaging System
(UVP, CA, USA). Densitometrical analyses were per-
formed (protein of interest and b-actin) using the Gel-
Doc 2000 and the Quantity One software (Bio-Rad,
Mississauga, ON, Canada). Results were expressed as a
ratio (protein of interest/b-actin) to correct for loading
for each endometrial sample.
Prostaglandin metabolites enzyme immunoassay
After collection from the animals, blood was allowed to
clot for 30-60 min at 37°C. The serum was then sepa-
rated from the clot and any remaining insoluble material
removed by centrifugation at 3500 rpm for 10 min at
4°C. After preparation, serums were kept at -80°C until
further use. EIAs for prostaglandins metabolites were
performed according to manufacturer’s instructions.
Briefly, 50-μl of serum was used for each of the PGF2a
Figure 1 The expression of COX-1 protein in rat endometrium during pregnancy. Total endometrial proteins were collected at indicated
days of pregnancy and were analysed by western blotting. Representative blots are shown (1A&1B). Histograms show densitometric analysis of
COX-1 normalized to b-actin to correct for protein loading (1C). Data represents the mean ± SEM of 3-4 independent experiments. Columns
with different superscripts are significantly different (p < 0.05).
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goat anti-rabbit IgG antibodies. 50 μl of metabolite tra-
cer and 50 μl of the metabolite specific antibody were
added to each well. The plates were incubated over-
night at 4°C or room temperature depending on the
metabolite. Then, wells were washed five times with
10 mM phosphate buffer (pH 7.4) containing Tween-
20 (0.05%) at pH 7.4; and 200 μl of Ellman’s reagent
(69 mM acetylthiocholine and 54 mM 5,5’-dithio-bis
[2-nitrobenzoic acid] in 10 mM phosphate buffer, pH
7.4) was added to each well and plates were incubated
in the dark at room temperature for 60-90 min. This
allowed the bound enzyme tracer to react with Ell-
man’s reagent to yield a yellow solution that can be
measured photometrically with a microplate reader at
420 nm. A standard curve was made simultaneously
with standards of the PGs metabolites, and determina-
tion of metabolite concentrations relative to those
standards was calculated.
Statistical analysis
All the experiments of pregnant animals were repeated
3-4 times. Endometrial extracts from each rat were
assessed individually. Results subjected to statistical ana-
lyses were expressed as mean ± SEM. Data were sub-
jected to one-way ANOVA (PRISM software version 4.0;
GraphPad, San Diego, CA). Differences between experi-
mental groups were determined by the Tukey’s test.
Results
Expression of COX-1 protein in the pregnant rat
endometrium
Western analyses were performed using lysates of preg-
nant uteri to analyze COX-1 protein levels during rat
pregnancy (Fig. 1). We found that COX-1 protein was
significantly increased at days 4 to 5.5 of early pregnancy
(implantation) and its expression was maximal at days 21
and 22 (parturition). Moreover, the enzyme was almost
undetectable from days 8 to 16 of pregnancy (Fig. 1).
Figure 2 The expression of COX-2 protein in rat endometrium during pregnancy. Total endometrial proteins were collected at indicated
days of pregnancy and were analysed by western blotting. Representative blots are shown (2A & 2B). Histograms show densitometric analysis of
COX-2 normalized to b-actin to correct for protein loading (2C). Data represents the mean ± SEM of 3-4 independent experiments. Columns
with different superscripts are significantly different (p < 0.05). Concentration of PGE2 and PGF2 a metabolites in the serum of pregnant rats
(2D&2E). Serum samples were collected at indicated days of pregnancy and the metabolites were measured using a high sensitivity enzyme
immunoassay (EIA) kit. Data represents the mean ± SEM of four independent experiments. *Significantly different from all other days of
pregnancy (p < 0.05).
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To document the trends of COX-2 protein in the rat
uterus during pregnancy, western analyses were per-
formed on lysates of pregnant rat endometrium (Fig. 2).
Our results showed that COX-2 protein was not present
at all days of pregnancy but was rather induced during
specific stages of pregnancy. COX-2 protein was present
in pregnant rats endometrial cells from days 2 to 5 (pre-
implantation period) and was induced from days 8 to
12; maximal level was reached at day 12 (decidual
regression). The enzyme was undetectable from days 18
to 21 but was induced at days 21 and 22 (parturition).
To determine if the augmentation of cyclooxygenases
at specific times of pregnancy was followed by an
increase in production of PGE2 and PGF2a,P G E 2
(13,14-dihydro-15-keto metabolite) and PGF2a (13,14-
dihydro-15-keto-PGF2a) metabolites were measured at
t h es a m et i m eb yE I Ai ns e r u mf r o mp r e g n a n tr a t s .
According to our results, PGE2 and PGF2a metabolites
were slightly increased at day 5.5 of pregnancy as com-
pared to day 1-5 (Fig. 2D and 2E). Statistically signifi-
cant increase in levels of prostaglandin E2 and F2a
metabolites was observed at days 10, 12 and 14 for
PGE2 metabolite (Fig. 2D), and at day 14 for PGF2a
metabolite (Fig. 2E) during decidua basalis regression.
Expression of COX-1 and COX-2 during pseudopregnancy
To determine whether COX proteins were modulated
by 17b-estradiol and progesterone in the endometrium
during pregnancy, Western analyses were performed on
Figure 3 The expression of COX-1 (3A) and COX-2 proteins (3C) in rat endometrium during pseudopregnancy.T o t a le n d o m e t r i a l
proteins were collected at indicated days of pseudopregnancy and were analysed by western blotting. Representative blots are shown.
Histograms show densitometric analysis of COX-1 and COX-2 normalized to b-actin to correct for protein loading (3B&3D). Data represents the
mean ± SEM of 3-4 four independent experiments. Concentration of PGE2 and PGF2a metabolites in serum from pseudopregnant rat (3E&3F).
Serum samples were collected at indicated days of peudopregnancy and the metabolites were measured using a high sensitivity enzyme
immunoassay (EIA) kit. Data represents the mean ± SEM of four independent experiments. Columns with different superscripts are significantly
different (p < 0.05).
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trium (Fig. 3A-D). COX-1 was significantly increased at
day 5 of pseudopregnancy (decidualization), while COX-
2 was undetectable at day 5 but increased gradually and
was maximal at day 9 (period preceding decidual regres-
sion). These results indicate that sex steroids can modu-
late the expression of COX enzymes in the
endometrium, although the two enzymes would be dif-
ferentially regulated. During pseudopregnancy, PGE2
and PGF2a metabolites similarly reached maximal con-
centration on day 7 (Fig. 3E and 3F).
COX-1 and COX-2 expression in female rat endometrium
during the estrous cycle
Western analyses performed on endometrial lysates at
different phases of the estrous cycle (diestrus, proes-
trus, estrus and metestrus) revealed a higher level of
COX-2 at the estrus phase compared to the other
phases (Fig. 4C). There was no significant change in
COX-1 protein expression (Fig. 4A). However, during
the estrous cycle, significantly higher levels of PGE2
and PGF2a metabolites were observed at proestrus
phase (Fig. 4E and 4F).
Figure 4 The expression of COX-1 (4A) and COX-2 proteins (4C) in rat endometrium during estrous cycle. Total endometrial proteins
were collected at indicated days from polyoestrus cycling rats at each stage of the estrous cycle (diestrus, proestrus, estrus and metestrus) and
subjected to western blots analysis of COX-1 and COX-2 content. Representative blots are shown. Histograms show densitometric analysis of
COX-1 and COX-2 normalized to b-actin to correct for protein loading (4B&4D). Data represents the mean ± SEM of 3-4 independent
experiments. Concentration of PGE2 and PGF2 a metabolites in serum of polyoestrus cycling rats at different stages of the estrous cycle
(diestrus, proestrus, estrus and metestrus) (4E&4F). Serum samples were collected at indicated stage of estrous cycle and the metabolites were
measured using a high sensitivity enzyme immunoassay (EIA) kit. Data represents the mean ± SEM of four independent experiments. Columns
with different superscripts are significantly different (p < 0.05).
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endometrium
To localize COX-1 and COX-2 proteins, uterine tissues
from pregnant rats were sectioned and immunofluores-
cence analyses were performed (Fig. 5 and 6). The results
showed that both enzymes were mostly present in lumi-
nal and glandular endometrial epithelial cells, but also to
a lesser extent in the stroma. We have found high levels
of COX-1 immunoreactivity on days 5.5 (implantation)
and 22 (parturition) and at day 9 of pseudopregnancy
(Fig. 5). As observed using western analyses, COX-1
expression was low on day 10 of pregnancy and day 1 of
pseudopregnancy. COX-2 signal at estrus, and on days
10 and 22 of pregnancy were found to be maximum (Fig.
6). Expression of COX-2 was low on days 5.5 and 20 of
pregnancy. These results were in accordance with COX-1
and COX-2 protein expression as demonstrated by wes-
tern analyses (Fig. 1, 2, 3, 4).
Figure 5 Immunofluorescence staining of COX-1 protein in rat endometrium during pregnancy, pseudopregnancy and estrous cycle.
COX-1 localization (green color) was assessed in rat endometrium during pregnancy (days 5.5, 10, 20 and 22), pseudopregnancy (days 1 and 9)
and estrous cycle (at estrus). Tissues were counterstained with Hoechst to stain nuclei (blue). For negative control (C-) primary antibody was
replaced by normal rabbit IgG. Results are representative of three independent experiments. Magnification: 200×. PD: pseudopregnancy.
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stromal cells
In order to study and confirm the role of steroid hor-
m o n e si nm o d u l a t i o no fC O X - 1a n dC O X - 2 ,p r i m a r y
stromal decidual cells from rat uterus were treated with
estradiol and progesterone in the presence and absence
of their respective antagonists (Fig 7). Our results
showed that there was no significant change in the pro-
tein expression of COX-1(7A&7B), whereas COX-2
l e v e l sw e r ef o u n dt ob ei n c r e a s e di nt h ep r e s e n c eo f
Figure 6 Immunofluorescence staining of COX-2 protein in rat endometrium during pregnancy, pseudopregnancy and estrous cycle.
COX-2 localization (green color) was assessed in rat endometrium during pregnancy (days 5.5, 10, 20 and 22), pseudopregnancy (days 1 and 9)
and estrous cycle (at estrus). Tissues were counterstained with Hoechst to stain nuclei (blue). For negative control (C-) primary antibody was
replaced by normal rabbit IgG. Results are representative of three independent experiments. Magnification: 200×. PD: pseudopregnancy.
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cells with ICI-182,780 prevents the increase in COX-2
with estradiol treatment. In contrast, progesterone and
its antagonist RU-486 had no effect on the modulation
of cyclooxygenases.
Discussion
In the last few years our laboratory has developed an
expertise in female rat reproductive functions [7,14,15].
In the present study, we have used rat as a model to
characterize the presence, activity and regulation of
COX-1 and COX-2 by sex steroids at specific stages in
the pregnant, pseudopregnant and non-pregnant rat
uterus.
COX-1 is known to be a constitutive enzyme that
plays “housekeeping” functions in many tissues. Our
results, nonetheless, demonstrate that COX-1 protein
level can be down-regulated in the rat endometrium;
indeed, COX-1 expression was almost undetectable
from days 10 to 16 of pregnancy during decidual regres-
sion period. COX-1 expression is probably regulated by
sex steroid hormones in vivo, since COX-1 levels were
elevated at specific days of pseudopregnancy. The
increase in COX-1 expression at the time of parturition
is in agreement with the studies by Reese and collabora-
tors, who had shown that COX-1 is a major source of
PGs during parturition and is essential for successful
parturition [3]. Collectively our results suggest the possi-
ble involvement of COX-1 in implantation and parturi-
tion, but not in the process of decidual regression.
In this study, we did not observe a significant increase
of COX-2 during implantation, but COX-2 has also
been detected at the beginning of pregnancy from day 2
to 5. Increase in COX-2 expression in epithelial and
stromal cells was also detected using immunostaining
w h i c hi si na c c o r d a n c ew i t ht h es t u d yb yC o n get al
[16]. In the past, gene knockout studies have revealed
that COX-2 -/- mice showed implantation and decidua-
lisation defects during pregnancy [4,5]. Interestingly,
experiments with COX-1 -/- mice revealed that the loss
of COX-2 can be compensated by COX-1 to rescue
female infertility [17]. By analyzing the quantity of PGE2
and PGF2a metabolites during pregnancy and pseudo-
pregnancy, we observed an augmentation of both meta-
bolites at from day 10-14 in case of pregnancy and day
7 of pseudopregnancy and the trends were similar to
Figure 7 The expression of COX-1 (7A) and COX-2 proteins (7C) in primary cultured rat stromal cells. The stromal cells were pre-treated
with anti-estrogen ICI-182,780 and anti-progestin RU-486 at concentration of 1 μM for 1 hr, followed by stimulation with estradiol and
progesterone at concentration of 100 nM for 48 h. Histograms show densitometric analysis of COX-1 and COX-2 normalized to b-actin to correct
for protein loading (7B&7D). Data represents the mean ± SEM of four independent experiments. Columns with different superscripts are
significantly different (p < 0.05).
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the augmentation of COX-2 is responsible in majority
for the augmentation of PGE2 and PGF2a during this
period. Therefore, COX-2 plays a major role during the
regression of decidua by producing PGE2 and PGF2a.
Moreover, the variation of COX-2 expression during
pseudopregnancy indicates that the enzyme is not only
influenced by the implanting blastocyst during early
pregnancy but also by steroid hormones produced by
maternal tissue. This was further confirmed by in vitro
stromal cell culture, where COX-2 expression was found
to be modulated by estradiol treatment. Moreover, in
normal pregnancy COX-1 is increased through day 5.5
and COX-2 is gradually increased from day 8 to 12,
while in the pseudopregnant model, COX-1 expression
is maximal at day 5 and COX-2 expression is maximal
at day 12. Thus, these results further suggest that the
model of pseudopregnancy mimics well the in vivo
situation.
During estrous cycle, our results demonstrated a sig-
nificant increase in PGE2 metabolite at proestrus phase
where apoptotic death is known to be absent. Recent
studies showed that PGE2 induces proliferation of
human endometrial epithelial cells [18]. The significant
increase of PGE2 metabolite at proestrus may suggest
its implication in cellular proliferation as seen in the
endometrium during this period preceding embryo
implantation. It is clearly evident from the studies of
Kennedy et al.[19] that PGE2 is involved in decidualiza-
tion. In the present study, we also demonstrated that
PGE2 might be involved in decidua basalis regression
since it is significantly increased during this specific per-
iod of pregnancy. Recent study from our laboratory has
shown that TGF-b isoforms are increased in the decidua
basalis and induced apoptosis in decidual cells in vitro
suggesting that TGF-b m i g h tb ei n v o l v e di nd e c i d u a
basalis regression [15]. Whether TGF-b induces decidual
cells apoptosis through the induction of COX-2 and
consequently an increase of prostaglandins remains to
be elucidated during rat pregnancy. Some studies have
suggested a role for TGFb1i nt h ei n d u c t i o no fC O X - 2
and PGE2 production in mink lung epithelial cells
(Mv1Lu) [20]. Thus similar mechanisms could be
involved in the regulation decidua basalis regression in
the rat endometrium during pregnancy.
In conclusion, these results characterize the expression
and localization of COX-1 and COX-2 in the non-preg-
nant, pregnant and pseudopregnant rat uterus and also
show that these two enzymes are the key factors
involved in embryo implantation, decidualization,
decidua basalis regression and parturition. Further, the
presence of these enzymes in the endometrium might
be directly or indirectly involved in the control of cell
apoptosis during implantation and decidual regression
which could be regulated by steroid hormones.
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